Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia
2 other identifiers
interventional
96
1 country
1
Brief Summary
Based on the theory of embodied cognition, which focuses on the influence of sensory and motor processes on cognition, researchers propose to study the influence of the action on memorization and inhibition in patients suffering from schizophrenia, using a directed forgetting paradigm. The directed forgetting paradigm is used, composed of two lists of action verbs. The instruction "to forget" is given at the end of learning the first list (To Be Forgotten (TBF)), following a simulation of a computer bug. Therefore a second list is presented to be learned and remembered (To Be Remembered (TBR)). A recognition task is performed at the end. The action verbs had to be encoded using four conditions: action performed, mimed, imagined action, action with a contextual word, reading the action verb only. 48 schizophrenic patients were included in this study. Patients were randomized to have 10 participants per condition. 48 controls matched by age, gender, laterality and education are also included and randomized in the same modality. This study aims to show that the encoding of sensory-motor components, more than providing a context could improve the inhibitory capacities but also memory in schizophrenia, and possibly be used in remediation cognitive.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started May 2011
Shorter than P25 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 31, 2015
CompletedFirst Posted
Study publicly available on registry
September 2, 2015
CompletedMarch 23, 2016
August 1, 2015
1.6 years
August 31, 2015
March 22, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of items recalled TBR and TBF
It is asked to the participants to recall orally, only TBR verbs (task of reminder). The experimenter notes the given verbs.
Day 1
Secondary Outcomes (2)
Number of recognized items
Day 1
Reaction time (ms) on the recognition of TBR and TBF
Day 1
Study Arms (8)
Patients group 1
EXPERIMENTALMemorization of the verbs by miming the action
Patients group 2
EXPERIMENTALMemorization of the verbs by imagining the action
Patients group 3
EXPERIMENTALMemorization of the action verbs by means of another word
Patients group 4
EXPERIMENTALSimple memorization of the verbs
Healthy volonteers group 1
ACTIVE COMPARATORMemorization of the verbs by miming the action
Healthy volonteers group 2
ACTIVE COMPARATORMemorization of the verbs by imagining the action
Healthy volonteers group 3
ACTIVE COMPARATORMemorization of the action verbs by means of another word
Healthy volonteers group 4
ACTIVE COMPARATORSimple memorization of the verbs
Interventions
The participant reads aloud the verbs that appear on the screen, by performing the corresponding action verb.
The participant reads aloud the verbs that appear on the screen, by imagining the corresponding action verb.
The participant reads aloud the verbs that appear on the screen. Then, he reads, without memorizing it, a word associated with the action verb to be learnt to favor the memorization of that one. The word is written near the action verb.
The participant reads aloud the verbs that appear on the screen, without additional instructions (control condition).
Eligibility Criteria
You may qualify if:
- Schizophrenic patients as defined in Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV)
- Stabilized a therapeutic point of view for at least one month.
- Consent form signed
- Affiliated to a Security Health Program
- Consent form signed
- Affiliated to a Security Health Program
You may not qualify if:
- Not having a history of head trauma, neurological disease or not stabilized serious somatic illness,
- Not to use psychoactive substance, as defined by the DSM IV.
- The Intelligence Quotient must not be less than 70 (Progressive Matrices Standard score (PM38), Raven Progressive Matrix).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de SAINT-ETIENNE
Saint-Etienne, 42000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne GROSSELIN, MD
CHU de Saint-Etienne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2015
First Posted
September 2, 2015
Study Start
May 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
March 23, 2016
Record last verified: 2015-08
Data Sharing
- IPD Sharing
- Will not share